| Primary site | Number in the study | Status | Age | Breed | Menopause | Surgical menopause | Hepatopathy | Histology | Diagnosis data | Stage | Current situation | Pretreatment | If CT, number of rows | Last CT | Previous CA-125 (U/mL) | Sample collection | Current CA-125 (U/mL) |
| OVARY | 1 | Elegible | 55 | White | After | No | No | Serous adenocarcinoma | 08/25/2011 | III | Under treatment | CT | 1 | 11/30/2012 | 12210.00 | 2011/8/12 | 139.00 |
| OVARY | 2 | Elegible | 37 | Pardo | After | Yes | No | Serous Boderline | 2008/1/4 | IV | Relapse | SG and CT | 1 | 2011/9/12 | 116.40 | 2011/9/12 | 82.20 |
| BREAST | 3 | Elegible | 69 | White | After | No | No | Invasive ductal carcinoma | 2009/4/5 | I | Complete remission | SG, RT and CT | 1 | 12/29/2010 | NA | 12/13/2011 | 28.3 |
| OVARY | 4 | OVARY FAILURE | N/A | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 12/13/2011 | 21.9 |
| OVARY | 5 | OVARY FAILURE | 49 | Black | Before | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 12/13/2011 | 290 |
| OVARY | 6 | Elegible | 55 | Yellow | After | Yes | No | Serous adenocarcinoma | 2000/4/8 | IV | Under treatment | SG | 1 | 2012/7/10 | 104.00 | 12/19/2011 | 103.80 |
| GASTRO | 7 | Elegible | 80 | Pardo | After | No | No | Adenocarcinoma | 2009/4/5 | I | Complete remission | SG | NA | NA | NA | 12/19/2011 | 11.9 |
| OVARY | 8 | OVARY FAILURE | 56 | White | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 12/19/2011 | 22.6 |
| BREAST | 9 | CONTROL FAILURE | 44 | Pardo | Before | No | No | Ductal carcinoma | NA | II | Complete remission | SG, RT, CT and HT | NA | 2010/10/12 | NA | 12/19/2011 | 19.5 |
| OVARY | 10 | Elegible | 59 | White | After | Yes | No | Adenocarcinoma | 2007/1/1 | III | Under treatment | SG and CT | 3 | 12/14/2011 | 1024.00 | 12/19/2011 | 911.40 |
| GASTRO | 11 | Elegible | 73 | White | After | No | No | Adenocarcinoma | 05/14/2007 | IV | Complete remission | SG | 1 | 2209/1/3 | NA | 12/20/2011 | 8 |
| OVARY | 12 | OVARY FAILURE | 49 | White | Before | No | No | NA | NA | III | Under treatment | CT | 1 | NA | NA | 12/20/2011 | NA |
| OVARY | 13 | Elegible | 62 | White | After | Yes | No | Serous adenocarcinoma | 2005/1/8 | III | Under treatment | SG, RT, CT and HT | >4 | 08/18/2011 | 122.00 | 12/21/2011 | 264.00 |
| BREAST | 14 | Elegible | 76 | White | After | No | No | Ductal carcinoma | 2006/1/6 | I | Complete remission | SG, RT and HT | NA | NA | NA | 12/26/2011 | 4.6 |
| GASTRO | 15 | Elegible | 69 | White | After | No | No | Adenocarcinoma | 04/29/2010 | II | Complete remission | SG | NA | NA | NA | 12/26/2011 | 17 |
| OVARY | 16 | Elegible | 75 | White | After | No | No | Ductal carcinoma | 02/13/2010 | IV | Under treatment | CT | NA | 02/19/2011 | 299.00 | 12/27/2011 | 254.00 |
| GASTRO | 17 | Elegible | 75 | White | After | No | No | Adenocarcinoma | 2010/1/8 | II | Complete remission | SG | NA | NA | NA | 2012/10/1 | 8.8 |
| BREAST | 18 | Elegible | 57 | White | After | No | No | Carcinoma Ductal | 2010/1/11 | I | Complete remission | SG, RT, CT and HT | 1 | 08/31/2010 | NA | 2012/10/1 | 16.3 |
| OVARY | 19 | OVARY FAILURE | 40 | White | After | No | No | Serous adenocarcinoma | NA | III | Under treatment | SG | NA | 01/21/2012 | 16.9 | 01/19/2012 | 17.6 |
| OVARY | 20 | OVARY FAILURE | 56 | White | After | Yes | No | Serous adenocarcinoma | 2012/9/3 | IV | NA | SG and CT | 2 | 12/22/2012 | NA | 01/19/2012 | 7.4 |
| BREAST | 21 | CONTROL FAILURE | 47 | White | Before | No | No | Ductal | NA | III | Complete remission | SG and HT | NA | NA | NA | 01/19/2012 | 11.4 |
| BREAST | 22 | Elegible | 67 | White | After | No | No | Ductal carcinoma | 12/29/2008 | I | Complete remission | SG, RT, CT and HT | 1 | 2009/4/5 | NA | 01/23/2012 | 12.2 |
| BREAST | 23 | Elegible | 54 | White | After | No | No | Ductal carcinoma | 2011/1/2 | I | Complete remission | SG, RT and HT | NA | NA | NA | 01/23/2012 | 15.2 |
| OVARY | 24 | OVARY FAILURE | 73 | NA | After | Yes | No | Serous adenocarcinoma | 2010/1/4 | III | Under treatment | SG and CT | 3 | 01/24/2012 | 5.1 | 01/23/2012 | 4.9 |
| OVARY | 25 | OVARY FAILURE | 77 | White | After | No | No | Poorly differentiated carcinoma | 2011/11/8 | III | Under treatment | NA | NA | 2012/6/1 | 6.5 | 02/23/2012 | 6.3 |
| OVARY | 26 | Elegible | 65 | White | After | No | No | Adenocarcinoma | 05/25/2011 | III | Under treatment | CT | NA | 2011/1/11 | 126.00 | 01/26/2012 | 72.50 |